Press Release

CREATIVE DIAGNOSTICS LAUNCHES NEW AZAPERONE TEST REAGENTS FOR RESEARCH APPLICATIONS



Creative Diagnostics has announced the release of its new line of Azaperone Test Reagents.

FOR IMMEDIATE RELEASE

16/10/2023

Creative Diagnostics, a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for food, feed, environmental and toxicological sample analysis, has announced the release of its new line of Azaperone Test Reagents, including Azaperone ELISA Kits, Azaperone Residue Rapid Test Strips, and Azaperone Antibodies & Antigens. These reagents are designed to assist researchers in the detection of Azaperone.

Azaperone is an important butylphenol benzene neurostabilizer used in veterinary practice. It has a variety of neurostabilizing effects associated with farm animals. Intramuscular injections of this drug are used to relieve tension and reduce activity in animals. It causes animals to be indifferent to their environment and remain calm for long periods, which helps to avoid fighting when they live together and mix in herds. For this reason, it is often used for long-distance transportation of animals such as pigs. With the widespread use of this drug in the veterinary field, the problem of its residues in animal tissues and the direct danger of its toxic side effects on human health have attracted widespread attention.

Creative Diagnostics is committed to developing quality detection reagents to support the development of sedative testing. Through years of research and experience of its technical staff, the company has successfully developed a range of antigens and antibodies for immunoassays and established enzyme-linked immunosorbent assay (ELISA) and lateral flow immunoassay (LFIA) detection platforms.

Creative Diagnostics now offers a series of Azaperone Test Reagents for research applications, including Azaperone Antibodies & Antigens, Azaperone ELISA Kits, and Azaperone Screen Tests. For example, the new Azaperone [OVA] (#DAGA-227O) and Mouse Anti-Azaperone Monoclonal Antibody (#CABT-L3081) can be used to detect Azaperone residues by ELISA and IFIA. These antigens and antibodies have been extensively validated and characterized. Meanwhile, the antigens are analyzed by UV-visible spectroscopy and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Antibody sensitivity is determined by icELISA to determine the 50% inhibitory concentration (IC50), and antibody specificity is determined by measuring cross-reactivity (CR) with other structural analogs.

Creative Diagnostics also offers icELISA for the detection of Azaperone residues in pork and pork liver. The linear range of the kit has been tested to be 0.165-1.29 ng/mL with a sensitivity of 0.5 ng/mL or greater. The CV is less than 15%. In addition, Creative Diagnostics provides Lateral Flow ICA Test Strip, a faster and easier diagnostic tool for on-site testing. The visual limit of detection and critical value for azaperone in Lateral Flow ICA are 0.5 and 10 ng/g, respectively. Both methods are sensitive, fast, and effective for on-site testing and rapid bulk screening of samples.

For more information about these new Azaperone Test Reagents, please visit https://www.creative-diagnostics.com/food-analysis/azaperone.html.

About Creative Diagnostics

Creative Diagnostics is a leading manufacturer and supplier of antibodies, small molecule conjugates and critical assay reagents for the analysis of food, feed, environmental and toxicological samples. Its product portfolio covers a wide range of analytes including mycotoxins, drug residues, pesticides, contaminants, food allergens, food pathogens and vitamins. The company also assists customers in the rapid development, manufacture and commercialization of small molecule antigens, antibodies and food safety lateral flow strips for any market segment.

Tags:
Azaperone Test Reagents  |  Creative Diagnostics  |  

---

Organisation Profile:
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.






Press release contact details for Creative Diagnostics

NameCreative Diagnostics
Tel
Fax
Email
Websitehttps://www.creative-diagnostics.com/
OrganisationCreative Diagnostics
Address
Town
County0
Postcode11967




Other press releases from Creative Diagnostics

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing Read more: https://www.digitaljournal.com/pr/news/getnews/creative-diagnostics-announces-new-mbc-assay-for-antibacterial-testing#ixzz8KcL65cji
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Launches New P53 and TP53 Antibodies for Cancer Research
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Citrinin Test Reagents for Food Safety
Creative Diagnostics Announces Novel Agar Gel Precipitin Tests for Viral Antigen Detection
Creative Diagnostics Introduces Cutting-Edge Anti-AAV Antibody ELISA Kits for Gene Therapy Research
Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection
Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development
Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.